General
Preferred name
NAPHAZOLINE HYDROCHLORIDE
Synonyms
NAPHAZOLINE HCL ()
Albalon ()
Rhinantin ()
Naphazoline (hydrochloride) ()
Naphthazoline (hydrochloride) ()
Vasocon ()
Naphazoline Nitrate ()
Antistin-Privine ()
Nafazair ()
Naphcon Forte ()
Gppe Nsl Soln ()
Opcon ()
NSC-35711 ()
Naphcon ()
Naphaz HCl ()
P&D ID
PD001845
CAS
550-99-2
35412-62-5
835-31-4
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Adrenergic (vasoconstrictor)
First approval
1971
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Cell lines
0
Organisms
1
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
EU-OPENSCREEN Bioactive Compound Library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
23
Properties
(calculated by RDKit )
Molecular Weight
246.09
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
2.81
TPSA
24.39
Fraction CSP3
0.21
Chiral centers
0.0
Largest ring
6.0
QED
0.87
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Neuroscience
GPCR/G protein
Apoptosis
Immunology/Inflammation
Neuronal Signaling
Protein Tyrosine Kinase/RTK
Target
Adrenergic Receptor
Interleukin Related
TNF Receptor
VEGFR
Source data